RIBAL NAJIB HADDAD

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology URBANA, IL NPI 1306331889

General Payments — all program years on this page

$3,999.00

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $838.63 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $838.6312

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
EMD Serono, Inc. $368.896
ABBVIE INC. $124.831
Amgen Inc. $120.421
NOVARTIS PHARMACEUTICALS CORPORATION $84.681
E.R. Squibb & Sons, L.L.C. $72.951
TG THERAPEUTICS, INC. $40.391
ARGENX US, INC. $26.471

By program year

Program yearAmountRecords
2019 $343.703
2020 $120.311
2021 $124.831
2022 $903.989
2023 $1,667.5530
2024 $838.6312

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086857493 Novartis Pharmaceuticals Corporation $84.68 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101394550 E.R. Squibb & Sons, L.L.C. $72.95 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103859445 ABBVIE INC. $124.83 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117570647 Amgen Inc. $120.42 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120241711 EMD Serono, Inc. $143.95 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120245041 EMD Serono, Inc. $25.35 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120248569 EMD Serono, Inc. $23.41 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120249189 EMD Serono, Inc. $93.54 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120251486 EMD Serono, Inc. $63.97 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120257338 EMD Serono, Inc. $18.67 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136884652 TG Therapeutics, Inc. $40.39 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142124855 ARGENX US, INC. $26.47 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.